Intellectual Property Magazine
Pharma patent agreements ‘contrary’ to EU competition law
Ben Wodecki
The Court of Justice for the EU (CJEU) has ruled that a settlement agreement between a pharma patent holder and a generic
manufacturer not to enter a specific market in return for monetary payments, is contrary to EU competition law.